{"ticker": {"uuid": "888dbd1e-a9f6-46a1-a075-42380ece281d", "symbol": "AMARIN", "name": "Amarin Corporations Public Company Limited", "exchange": "SET", "country": "TH", "sector": "Communication Services", "industry": "Publishing"}, "articles": [{"title": "Amarin (NASDAQ: AMRN) CLO gets RSU shares; some withheld for tax", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNcThQR2Ffa1RyZjZmcDl1a013eDg5NGQtcnFCZzVSQVo2Vi11dGk2ZmNnbl9KRkFGdW41M0xnY3BjSUtvejUycUxRVGFOUmtRbVJuYVRZNWhLajFiSGp2NVJZLVowNEowcnFmejlTbXdkYmlSaWw3YWdDdndMbmtnU1BBTGg4MjFZQjFHRmxvRkFIQUtIQV9TQnc5emVJTnNZWXdGdGllTTUwZHZIVC01VklB?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:00:35+00:00", "published_display": "15 Jul 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin Corporation (AMRN) Sees Modest Uptick Amid Steady Trading - Active ETF Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNWGlleTdYNUpONFVxQTNfeTlaX2hWal9xSmprLVdSODVFM3E3T1EtOGJoekJZUmxMN1d0WFFlMGQ1XzVCaUoyWFNUUkJ6Z0VCMW16S1I1Tjl6ZDRmcVVIU0hHbUJzenY1MEJ4cmE3X01yTlY3ZzRFWXRhNEJTWmItaWJpVjdTdTVnS215d081MzBOcEk4U3FqNVFEaEY3NUlHamRvR2dZUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-15T15:40:20+00:00", "published_display": "15 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin: The Market Is Pricing A 55% Chance Of A Sale That Isn't Coming (NASDAQ:AMRN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNVDFtWHJqV1hzYmVJaDVqbGgxZ0p5MTNLU1F1azNzRzd4N2phR3ZSV1J1MzlDeGI4X2FnazdaRklMWDZzNklUZlkydWxtQ0dxTnZtLXk0d1M2QkJXckJia2tLY2hSMFVldmN1T1RHQU5vSWlkLXBzblk0V0R6NnJ2VE9hcDRTZmw3MkZPWWtWQ1BQNjZ5NEttXzFvRDR1amIxa09OZ3hudlFrcGMtcmJxaVBn?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin says VASCEPA remains a first-line option as triglyceride drugs expand", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPMG1RSUctS2JPVGdlVzRfRmVVdUQwV25IVkg4WmhVR0ZUVnNOekhpNnRoV3lvZUktQjNlUUdfVDVvdHpwazNiMjdOYTBPRnpvYUNZYjFCaEpQa2tSRVpSZWFCSi1aY0REX1k3WEpQVUo0RVl6NXhLMzN2SkJBUnhMSnMxbjBkamVmbjNTaFBTWThkd19fbHVPWEJxVUQ0aEd6SW11ZjdwVXBZb1I3Z0ctejVnVGZLTDRVSXh5aA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Amarin Corporation plc \u2013 NASDAQ:AMRN", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQOHdxTXBCa3ZkcHVpaUk3UDdDcGZBZHZFdTloUUVkdk92Z2NwWXpoV3FFVTlsVmJHMGQ4ekV3RlNUZHI3OEo0X013NHotcjN3ZmN6NDQ5d0JSWE8xeGF4VlRScjAtdzFic0w1VGRodkltNmZSaENJN0kxRWt5YnBnN0dVVEx0cDJIaUVrQ25MMHJRS0NYT0haX0RxdjlXUQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T18:02:18+00:00", "published_display": "26 Jun 2026 18:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPRDh1S2dlUFMxUEJmb0dfQndWRnQ5WHV4ZUE5Sm82R2FqRm9Ea0gyZHVIeGFPanlweEZOYmdWLWxqbW41UldpMDFaMXhnTklrcmhaM1dhVHdLTUMybXU2M25vT3RoamZUZERuNUJwTXFvakMxT1VmcmhwZFg5ZlR6OGRRdWhab1JXMUZCSW9RTGlfekZreGNId1RyWS0tZTRmR3BkZUpMOA?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supreme Court Rules in Favor of Hikma Pharmaceuticals, Impacting Amarin (AMRN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPcjd4R2RzSjMwc1p4cU5TRy1fNlByUnJtVVVKaXd6MThUWkhmblNQUnVodGpITmljUWJXZWZROGpLUXdMNExvS3RWWFVzNEF3UnRtZzJXX0pEeS16Qjgtcnl0QzVCU0ZLQThmcWZWTEdDTFI0TExLQXdmOTdzbTVsU0FYSVNkLWZHbDdOVHpBR3A4UF9JUXpvd3JDTkJTVkZDZTE5ajZveGYwaElORjJKYS1DcEJma2lHYm8xWGR6WC1GY1lO?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Amarin (AMRN) Story Is Shifting With A Refined Fair Value And Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNaGNyVUZ1MVNWcE5KNEtKT202WDRJMzBlVVRENG5ibHFsVmdjMVVOcWVxTVJKejlEWktXSEFtbGZQcVQ2UjA2QUpDYzhOaC1pMUhnUi1UdkFmUWxGV0F4bk1WazdMdXlRbWlMSjl3NkxTVmZfRFhFbHFoaF9LYUZwbVEtWm1SSkNKeTEyamxZMzFVT3p0WExDLUw5UkRraWpz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxObEc5YlZlclR2em1hdWtZM3V1S2lDUnZfTWhxTWFIY1FweUU5VzM3b25oMjdrSkItN2ZDTVNpcXRsOWhqWU5wOUx6RU1FZ3hXQzEtZkpqUmJyNVlBNXMtV09qZ3o4QmwzU1A4T2k3RTR6NjYySnVITEFhcHZvVExPNGV6aGRzTmV5Z28yZXV1RjRUNElOUmZ2OFZXRjc?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin (AMRN) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPSGlGVHdKZVZyS20ydnpwRUR3QjdBbVVoSFhrNXFBMFJmckpFTU11ZTIwbDdXcVFWQmFkR3MteVdfY2cwRldMc2dTNDIyXy1YWmtvSVprMHEwN1ZfWkpZdXdpSTQ4Tm1vclI5QWRvaVpzT0lKUDZfdFBCTWJJM1JoTGo1VU5wMGFaeURON21VWUFEdWd1eWlkeG11dTNaLTQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Y", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPWC04UG4tUzRhNnBUUkEyNW9WSzlsWDFsTTVJYVgxMGVDb0NPSUlvb29SbDc4T210Q3FtQzlobFAyNHhEUnlJbjhSbUd4bm4wOXNyai1JWU5Tb1hCN3BLUkc3T0pKbWx2d1V6ZGg4MzZNSkpBTzdqVUZ6TGswWFo0ekZNdDNIeFBOVmlBQUd2OFppRjlsWHdvZTktSm8xT1FobE9EUUtFVzN1cVh3eVN6RktXQ3c?oc=5", "source_name": "TradingView", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMARIN ($AMRN) Releases Q1 2026 Earnings | AMRN Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPemJlOHUyZ3pTbHpQNi1CaUt1RTNvRVNZVG9rQXBVX2dONWVhcTFEN2trWW9Da3Z2RVlURTlKck5kTFJwVlJFQkcyV2ZWOEtxdFZlRU1QU3ZyVDBpRDlrZGRJTGh6N21YUmotUy0zOUhBS05GWmpNQUZFYXZDTkZ3TmRzeWRWUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Amarin (AMRN) Story Is Shifting With An Unchanged US$12 Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQSGxTNW1mQldTZVNaeVNKYVB3WWV3Xzk2Zm1Lc3VISXRsUnZxeVZwS2kxSW1ZMWtWRHJ2MThVUmp2dUM4R2l3aGM5RDExT3B0X2VxclhtdHNIQ01LRHVodnRNRUVqLXRtZy0xaG5laERpanBUZUUycFBrTDlkay1FdkM2QnZkcjdtQXVLSTdHbFQyMDFrZlFLZVFRZ0J0czBObWN3?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Amarin (AMRN) Outpaced Other Medical Stocks This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOQXN3VGlPak1neE1ScGVBNnkxdTk1dHdXYnJtTzlEclljYm9TNTlRaTVIbFkzZmNHZDhWSDNiNWxUaE9lZThtblVxMHcyc1JzbUN6VW1HVy14dW1pVzd5UG4yMmRDUFNGUXplbzdHcHJFZllxTU1KbVNvQzNKczIyb1hIZVU0UEZwWWlwdmlxZUI5TmI5QlZzNHl6S00zbkRr?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin (AMRN) Q2 2025 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPRTNMRFp6SG1NUjJFd2o3eUx0SG1TLVhEQmtDSkFmNWtBbW1MYlFqYWYzRDJXcVVndTdpcXdyZkFnZlZBNnJoZ1Jxdi1WQm1LN2lMWnh1Smx1eU9NajFBWk91bC1wdVF2V2dGZDhLMjhmbUdIR01ZQkNoRkg1SzhOdXZaZC1kOGFTRllfZ0Vhcnl1U1FIRGo0eklXUC15RmM?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why I Wouldn't Touch Amarin With a 10\u2011Foot Pole Given Its Patent and Competition Risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPNXVkYTVVQXNyeHZVemgwMnd1MmpUMFhNR3NMTTdrTHY4TmVYdU8zUHk3SlRfamtvdVB2cHBVRVdWUnZsYklGYm02STFDYy1ZOVVxUkM5R0hkSWFyZjliWGRkM0FJdUFkd1NwdHROeXJJNkp4em13ck5Db3RxeUQ2c1BTWS0zTmtJWmFIOHBmTFpWdnN4bmNvZw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-07T08:00:00+00:00", "published_display": "07 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPMnlwWlVkemVvRGcyMjZrOHFhMEtBUWN5MW05VVc3UzV1eXNLaFFQUzdpaEo0SmpJQWhFM1hrN0sxeUdyN0RNWlRXU0dLMkNtRWFJUHhlWW1LUnR5eTdwSFZqYVR6MlVyaU1QMTBFZV9hbldvZ29xOVhTZldSbWx5OGZBLU9FcXBPZGFhVnE3MlROc0k?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin down as topline contracts in Q4", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNNDhCdWt1SnVET3dHMWpIMDlqRmtaQnJjaVQ2VDg4Y1RBRFFYZG5YeThRemYzU1BZV3NMRWZlWEVtbE5EcUtvU1NZcU52Tk0tdUw4R09MRVA5eVl2SWNBSVh4NlpaWWs3WUhKV0UyQWJUM0N6OFZFeVB0bTh0TUhrZTR3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirivadhanabhakdi Family Tenders for Entire Business of \u2018Amarin Corporations\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE9RQXVoTl9HVnMxZnlQeWpEb1pvMjMtY0JGRDRqTTF6aHFubld0dkwxNUp4Q0hIY1pnLUdheTdOYWN0MXpaX3dpZU8xX3kzMG16d3Q5NHJveDc0VDh5REd5bQ?oc=5", "source_name": "kaohoon international", "published_at": "2024-06-03T07:00:00+00:00", "published_display": "03 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMARIN", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNSGdHQkhpZU1TdEdxWmVncVFtVHk3TXpDaVNDWVV1cGtwSHlZRjlwWWZ3WGhFR1hIZWs3Q00wdkI0X1R2MjdxT1ExQmhLWVl3MnFuMzNOLTdOOXhCWHVvbnFRbmJrY3V3ZFBRREFIS1pqQlBEN2JfWFJkc0N4ZlZGemQ5Nm16RTJRNHM3ZHY3MA?oc=5", "source_name": "SET", "published_at": "2023-08-30T15:29:10+00:00", "published_display": "30 Aug 2023 15:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMARIN Stock Price and Chart \u2014 SET:AMARIN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE50V3pXZGhzZmtRQk10NWNrQjBYMUptV0k3QzdWQjdGME1OaDZhZWdtTnpzNHk4QVVqYTFEblo3a2VHT2hJbGEwUmJIbzVOenV5NnBzamw2S29Kczg?oc=5", "source_name": "TradingView", "published_at": "2018-08-17T17:07:15+00:00", "published_display": "17 Aug 2018 17:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Amarin (NASDAQ: AMRN) CLO gets RSU shares; some withheld for tax", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNcThQR2Ffa1RyZjZmcDl1a013eDg5NGQtcnFCZzVSQVo2Vi11dGk2ZmNnbl9KRkFGdW41M0xnY3BjSUtvejUycUxRVGFOUmtRbVJuYVRZNWhLajFiSGp2NVJZLVowNEowcnFmejlTbXdkYmlSaWw3YWdDdndMbmtnU1BBTGg4MjFZQjFHRmxvRkFIQUtIQV9TQnc5emVJTnNZWXdGdGllTTUwZHZIVC01VklB?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:00:35+00:00", "published_display": "15 Jul 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin Corporation (AMRN) Sees Modest Uptick Amid Steady Trading - Active ETF Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNWGlleTdYNUpONFVxQTNfeTlaX2hWal9xSmprLVdSODVFM3E3T1EtOGJoekJZUmxMN1d0WFFlMGQ1XzVCaUoyWFNUUkJ6Z0VCMW16S1I1Tjl6ZDRmcVVIU0hHbUJzenY1MEJ4cmE3X01yTlY3ZzRFWXRhNEJTWmItaWJpVjdTdTVnS215d081MzBOcEk4U3FqNVFEaEY3NUlHamRvR2dZUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-15T15:40:20+00:00", "published_display": "15 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin: The Market Is Pricing A 55% Chance Of A Sale That Isn't Coming (NASDAQ:AMRN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNVDFtWHJqV1hzYmVJaDVqbGgxZ0p5MTNLU1F1azNzRzd4N2phR3ZSV1J1MzlDeGI4X2FnazdaRklMWDZzNklUZlkydWxtQ0dxTnZtLXk0d1M2QkJXckJia2tLY2hSMFVldmN1T1RHQU5vSWlkLXBzblk0V0R6NnJ2VE9hcDRTZmw3MkZPWWtWQ1BQNjZ5NEttXzFvRDR1amIxa09OZ3hudlFrcGMtcmJxaVBn?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin says VASCEPA remains a first-line option as triglyceride drugs expand", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPMG1RSUctS2JPVGdlVzRfRmVVdUQwV25IVkg4WmhVR0ZUVnNOekhpNnRoV3lvZUktQjNlUUdfVDVvdHpwazNiMjdOYTBPRnpvYUNZYjFCaEpQa2tSRVpSZWFCSi1aY0REX1k3WEpQVUo0RVl6NXhLMzN2SkJBUnhMSnMxbjBkamVmbjNTaFBTWThkd19fbHVPWEJxVUQ0aEd6SW11ZjdwVXBZb1I3Z0ctejVnVGZLTDRVSXh5aA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Amarin Corporation plc \u2013 NASDAQ:AMRN", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQOHdxTXBCa3ZkcHVpaUk3UDdDcGZBZHZFdTloUUVkdk92Z2NwWXpoV3FFVTlsVmJHMGQ4ekV3RlNUZHI3OEo0X013NHotcjN3ZmN6NDQ5d0JSWE8xeGF4VlRScjAtdzFic0w1VGRodkltNmZSaENJN0kxRWt5YnBnN0dVVEx0cDJIaUVrQ25MMHJRS0NYT0haX0RxdjlXUQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T18:02:18+00:00", "published_display": "26 Jun 2026 18:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPRDh1S2dlUFMxUEJmb0dfQndWRnQ5WHV4ZUE5Sm82R2FqRm9Ea0gyZHVIeGFPanlweEZOYmdWLWxqbW41UldpMDFaMXhnTklrcmhaM1dhVHdLTUMybXU2M25vT3RoamZUZERuNUJwTXFvakMxT1VmcmhwZFg5ZlR6OGRRdWhab1JXMUZCSW9RTGlfekZreGNId1RyWS0tZTRmR3BkZUpMOA?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supreme Court Rules in Favor of Hikma Pharmaceuticals, Impacting Amarin (AMRN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPcjd4R2RzSjMwc1p4cU5TRy1fNlByUnJtVVVKaXd6MThUWkhmblNQUnVodGpITmljUWJXZWZROGpLUXdMNExvS3RWWFVzNEF3UnRtZzJXX0pEeS16Qjgtcnl0QzVCU0ZLQThmcWZWTEdDTFI0TExLQXdmOTdzbTVsU0FYSVNkLWZHbDdOVHpBR3A4UF9JUXpvd3JDTkJTVkZDZTE5ajZveGYwaElORjJKYS1DcEJma2lHYm8xWGR6WC1GY1lO?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Amarin (AMRN) Story Is Shifting With A Refined Fair Value And Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNaGNyVUZ1MVNWcE5KNEtKT202WDRJMzBlVVRENG5ibHFsVmdjMVVOcWVxTVJKejlEWktXSEFtbGZQcVQ2UjA2QUpDYzhOaC1pMUhnUi1UdkFmUWxGV0F4bk1WazdMdXlRbWlMSjl3NkxTVmZfRFhFbHFoaF9LYUZwbVEtWm1SSkNKeTEyamxZMzFVT3p0WExDLUw5UkRraWpz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxObEc5YlZlclR2em1hdWtZM3V1S2lDUnZfTWhxTWFIY1FweUU5VzM3b25oMjdrSkItN2ZDTVNpcXRsOWhqWU5wOUx6RU1FZ3hXQzEtZkpqUmJyNVlBNXMtV09qZ3o4QmwzU1A4T2k3RTR6NjYySnVITEFhcHZvVExPNGV6aGRzTmV5Z28yZXV1RjRUNElOUmZ2OFZXRjc?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin (AMRN) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPSGlGVHdKZVZyS20ydnpwRUR3QjdBbVVoSFhrNXFBMFJmckpFTU11ZTIwbDdXcVFWQmFkR3MteVdfY2cwRldMc2dTNDIyXy1YWmtvSVprMHEwN1ZfWkpZdXdpSTQ4Tm1vclI5QWRvaVpzT0lKUDZfdFBCTWJJM1JoTGo1VU5wMGFaeURON21VWUFEdWd1eWlkeG11dTNaLTQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Y", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPWC04UG4tUzRhNnBUUkEyNW9WSzlsWDFsTTVJYVgxMGVDb0NPSUlvb29SbDc4T210Q3FtQzlobFAyNHhEUnlJbjhSbUd4bm4wOXNyai1JWU5Tb1hCN3BLUkc3T0pKbWx2d1V6ZGg4MzZNSkpBTzdqVUZ6TGswWFo0ekZNdDNIeFBOVmlBQUd2OFppRjlsWHdvZTktSm8xT1FobE9EUUtFVzN1cVh3eVN6RktXQ3c?oc=5", "source_name": "TradingView", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMARIN ($AMRN) Releases Q1 2026 Earnings | AMRN Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPemJlOHUyZ3pTbHpQNi1CaUt1RTNvRVNZVG9rQXBVX2dONWVhcTFEN2trWW9Da3Z2RVlURTlKck5kTFJwVlJFQkcyV2ZWOEtxdFZlRU1QU3ZyVDBpRDlrZGRJTGh6N21YUmotUy0zOUhBS05GWmpNQUZFYXZDTkZ3TmRzeWRWUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Amarin (AMRN) Story Is Shifting With An Unchanged US$12 Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQSGxTNW1mQldTZVNaeVNKYVB3WWV3Xzk2Zm1Lc3VISXRsUnZxeVZwS2kxSW1ZMWtWRHJ2MThVUmp2dUM4R2l3aGM5RDExT3B0X2VxclhtdHNIQ01LRHVodnRNRUVqLXRtZy0xaG5laERpanBUZUUycFBrTDlkay1FdkM2QnZkcjdtQXVLSTdHbFQyMDFrZlFLZVFRZ0J0czBObWN3?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Amarin (AMRN) Outpaced Other Medical Stocks This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOQXN3VGlPak1neE1ScGVBNnkxdTk1dHdXYnJtTzlEclljYm9TNTlRaTVIbFkzZmNHZDhWSDNiNWxUaE9lZThtblVxMHcyc1JzbUN6VW1HVy14dW1pVzd5UG4yMmRDUFNGUXplbzdHcHJFZllxTU1KbVNvQzNKczIyb1hIZVU0UEZwWWlwdmlxZUI5TmI5QlZzNHl6S00zbkRr?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin (AMRN) Q2 2025 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPRTNMRFp6SG1NUjJFd2o3eUx0SG1TLVhEQmtDSkFmNWtBbW1MYlFqYWYzRDJXcVVndTdpcXdyZkFnZlZBNnJoZ1Jxdi1WQm1LN2lMWnh1Smx1eU9NajFBWk91bC1wdVF2V2dGZDhLMjhmbUdIR01ZQkNoRkg1SzhOdXZaZC1kOGFTRllfZ0Vhcnl1U1FIRGo0eklXUC15RmM?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why I Wouldn't Touch Amarin With a 10\u2011Foot Pole Given Its Patent and Competition Risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPNXVkYTVVQXNyeHZVemgwMnd1MmpUMFhNR3NMTTdrTHY4TmVYdU8zUHk3SlRfamtvdVB2cHBVRVdWUnZsYklGYm02STFDYy1ZOVVxUkM5R0hkSWFyZjliWGRkM0FJdUFkd1NwdHROeXJJNkp4em13ck5Db3RxeUQ2c1BTWS0zTmtJWmFIOHBmTFpWdnN4bmNvZw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-07T08:00:00+00:00", "published_display": "07 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPMnlwWlVkemVvRGcyMjZrOHFhMEtBUWN5MW05VVc3UzV1eXNLaFFQUzdpaEo0SmpJQWhFM1hrN0sxeUdyN0RNWlRXU0dLMkNtRWFJUHhlWW1LUnR5eTdwSFZqYVR6MlVyaU1QMTBFZV9hbldvZ29xOVhTZldSbWx5OGZBLU9FcXBPZGFhVnE3MlROc0k?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amarin down as topline contracts in Q4", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNNDhCdWt1SnVET3dHMWpIMDlqRmtaQnJjaVQ2VDg4Y1RBRFFYZG5YeThRemYzU1BZV3NMRWZlWEVtbE5EcUtvU1NZcU52Tk0tdUw4R09MRVA5eVl2SWNBSVh4NlpaWWs3WUhKV0UyQWJUM0N6OFZFeVB0bTh0TUhrZTR3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirivadhanabhakdi Family Tenders for Entire Business of \u2018Amarin Corporations\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE9RQXVoTl9HVnMxZnlQeWpEb1pvMjMtY0JGRDRqTTF6aHFubld0dkwxNUp4Q0hIY1pnLUdheTdOYWN0MXpaX3dpZU8xX3kzMG16d3Q5NHJveDc0VDh5REd5bQ?oc=5", "source_name": "kaohoon international", "published_at": "2024-06-03T07:00:00+00:00", "published_display": "03 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMARIN", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNSGdHQkhpZU1TdEdxWmVncVFtVHk3TXpDaVNDWVV1cGtwSHlZRjlwWWZ3WGhFR1hIZWs3Q00wdkI0X1R2MjdxT1ExQmhLWVl3MnFuMzNOLTdOOXhCWHVvbnFRbmJrY3V3ZFBRREFIS1pqQlBEN2JfWFJkc0N4ZlZGemQ5Nm16RTJRNHM3ZHY3MA?oc=5", "source_name": "SET", "published_at": "2023-08-30T15:29:10+00:00", "published_display": "30 Aug 2023 15:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMARIN Stock Price and Chart \u2014 SET:AMARIN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE50V3pXZGhzZmtRQk10NWNrQjBYMUptV0k3QzdWQjdGME1OaDZhZWdtTnpzNHk4QVVqYTFEblo3a2VHT2hJbGEwUmJIbzVOenV5NnBzamw2S29Kczg?oc=5", "source_name": "TradingView", "published_at": "2018-08-17T17:07:15+00:00", "published_display": "17 Aug 2018 17:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 21, "sentiment_summary": {"positive": 2, "negative": 2, "neutral": 17, "score": 51, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 9.5, "count": 16}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 2.04, "latest_week": "2026-07-17", "one_week_move": -8.1, "four_week_move": -20.9, "twelve_week_move": -32.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.498474, "market_dynamics_buy_signal": false, "relative_strength": -26.454101, "fair_value_gap": -34.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 32.3934, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.1% over one week, -20.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 5}, {"label": "The Motley Fool", "count": 4}, {"label": "TradingView", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "Seeking Alpha", "count": 2}, {"label": "dars.gov.et", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "Quiver Quantitative", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 16}, {"label": "Earnings", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-8.1% over one week, -20.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Amarin (NASDAQ: AMRN) CLO gets RSU shares; some withheld for tax"}], "updated_at": "2026-07-21T17:40:24.105647+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}